This inventor holds 10 USPTO granted patents. Top assignees: Sterling Winthrop Inc., Sanofi, Sanofi Pharmaceuticals, Inc.. Active years: 1994-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Town of East Greenbush, NY (US) (1994)
- Blue Bell, PA (US) (1994 - 1998)
- Belle Mead, NJ (US) (1996 - 1998)
- Scotch Plains Township, Union County, NJ (US) (1998)
- Belle Meade, NJ (US) (1998)
Company Filing History:


Years Active: 1994-1998
Title: The Innovative Contributions of Gee-Hong Kuo
Introduction
Gee-Hong Kuo is a notable inventor based in Blue Bell, Pennsylvania. He has made significant contributions to the field of therapeutic compounds, holding a total of 10 patents. His work focuses on the development of novel chemical compounds that have potential applications in medicine.
Latest Patents
Among his latest patents are the therapeutic phenoxyalkylazoles and phenoxyalkylazines. These compounds are characterized by complex chemical structures that include various substituents, enhancing their therapeutic potential. Another significant patent involves therapeutic phenoxyalkylheterocycles, which also feature intricate formulas designed for medicinal use.
Career Highlights
Gee-Hong Kuo has had a distinguished career, working with prominent companies such as Sterling Winthrop Inc. and Sanofi. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the advancement of therapeutic solutions.
Collaborations
Throughout his career, Kuo has collaborated with esteemed colleagues, including David J. Aldous and Thomas R. Bailey. These partnerships have fostered a collaborative environment that has led to the successful development of innovative compounds.
Conclusion
Gee-Hong Kuo's contributions to the field of therapeutic compounds exemplify his dedication to innovation and invention. His patents reflect a commitment to advancing medical science through the development of novel chemical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile